| Goods and Services | Business data analysis services in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development; Business consulting services in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development; Business consulting services relating to pharmaceutical portfolio prioritization, indication prioritization, asset prioritization, opportunity assessment, and clinical development strategy for pharmaceutical research and development; Business consulting services relating to the commercial evaluation of therapeutic targets, biomarkers, mechanisms of action, therapeutic indications, drug development opportunities, and pharmaceutical research opportunities; Market intelligence services in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development; Competitive intelligence services in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development; Providing business information and business analytics for pharmaceutical, biotechnology, and life sciences companies; Providing business information and business analytics relating to pharmaceutical portfolios, therapeutic areas, therapeutic indications, drug development opportunities, competitive landscapes, market opportunities, and research and development prioritization; Providing business information via a website in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development; Business research services in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development; Compilation, systematization, and updating of business data, market data, competitive intelligence data, pharmaceutical portfolio data, and drug development information in computer databases; Business data analytics services for identifying, evaluating, and prioritizing therapeutic areas, therapeutic indications, pharmaceutical assets, drug development opportunities, and market opportunities; Business advisory services relating to research and development portfolio strategy, pharmaceutical portfolio strategy, indication prioritization, market opportunity assessment, and competitive positioning in the fields of pharmaceuticals, biotechnology, life sciences, drug discovery, and drug development |
| Goods and Services | Downloadable software tools for biomedical data integration, visualization, and analysis; Downloadable application software for analyzing biomedical, medical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Downloadable local software toolboxes and locally installable software tools for biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data integration, curation, visualization, and analysis; Downloadable locally installable software tools for analyzing biomedical knowledge graphs, molecular interaction networks, drug-target relationships, mechanisms of action, biomarkers, therapeutic indications, drug development status, and drug safety-related information; Downloadable algorithms and software modules for updating, processing, integrating, curating, visualizing, and analyzing biomedical information; Downloadable software modules for processing biomedical knowledge graphs, molecular interaction networks, scientific literature-derived data, pharmacological data, clinical trial data, drug development data, and drug safety-related data; Downloadable software modules, plug-ins, and extensions for expanding, customizing, updating, and processing biomedical, pharmacological, drug development, and drug safety-related software functionalities; Downloadable software development tools and application programming interface (API) software modules for integrating biomedical, pharmacological, drug development, and drug safety-related analytics into local software environments; Downloadable application programming interface (API) software for accessing, querying, integrating, and analyzing biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Downloadable mobile applications for accessing and visualizing biomedical, pharmacological, drug development, and health-related analytics; Downloadable software for accessing cloud-based biomedical, pharmacological, drug development, and drug safety-related databases; Downloadable software for accessing and analyzing curated biomedical reference data, scientific publication-derived data, clinical trial information, pharmacological information, drug development information, and drug safety-related information; Downloadable software and algorithms for analyzing drug-target relationships, molecular mechanisms of action, biomarkers, disease biology, therapeutic indications, drug development status, adverse event information, toxicity information, contraindication information, drug-drug interaction information, risk information, and pharmacovigilance-related data; Downloadable software for identifying and analyzing relationships between genes, variants, diseases, phenotypes, biomarkers, drugs, targets, mechanisms of action, therapeutic indications, clinical trial information, drug development information, and drug safety-related information |
| Goods and Services | Providing software-as-a-service (SaaS) for target identification, target validation, and indication finding in early drug development; Software-as-a-service (SaaS) featuring software for biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data analysis; Software-as-a-service (SaaS) featuring software for integrating, curating, visualizing, and analyzing biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Platform-as-a-service (PaaS) featuring software platforms for integrating, curating, visualizing, and analyzing biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Providing online non-downloadable application programming interface (API) software for accessing, querying, integrating, and analyzing biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Providing temporary use of online non-downloadable API software for integrating biomedical, pharmacological, drug development, and drug safety-related analytics into third-party research software, local software environments, and cloud-based software environments; Providing non-downloadable software development tools, API software, and data interface software for accessing and analyzing biomedical knowledge graphs, molecular interaction networks, curated biomedical reference data, scientific publication-derived data, pharmacological data, clinical trial data, drug development data, and drug safety-related data; Providing bioinformatics tools and platforms for analyzing molecular interaction networks, disease biology, disease-phenotype relationships, biomarkers, drug-target relationships, mechanisms of action, therapeutic indications, and therapeutic opportunities; Providing bioinformatics and computational biology platforms for the integration and analysis of genes, variants, diseases, phenotypes, biomarkers, drugs, targets, mechanisms of action, clinical trial information, therapeutic indications, drug development information, and drug safety-related information; Providing temporary use of non-downloadable software for biomedical graph analytics, target identification, target validation, indication finding, and computational drug discovery; Providing non-downloadable software for integrating biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data to support early-stage drug development decisions; Providing non-downloadable software for analyzing drug-target relationships, mechanisms of action, molecular mechanisms, biomarkers, disease biology, therapeutic opportunities, potential indications, clinical trial information, drug development status, and drug safety-related information; Providing non-downloadable software for analyzing adverse event information, toxicity information, contraindication information, drug-drug interaction information, risk information, pharmacovigilance-related information, and similar safety-related content; Providing non-downloadable software for accessing and analyzing scientific publication-derived data, curated biomedical reference data, clinical trial data, drug development status information, pharmacological information, and drug safety-related information; Providing non-downloadable software for analyzing biomedical knowledge graphs, molecular interaction networks, scientific literature-derived data, curated biomedical reference data, pharmacological data, clinical trial data, drug development information, and drug safety-related information; Developing and providing cloud-based software tools for biomedical research, pharmaceutical research, drug discovery, drug development, bioinformatics, computational biology, biomedical data analytics, API-based data analytics, and biomedical software integration; Designing, developing, hosting, maintaining, and updating API-based software platforms, data interfaces, and cloud-based software platforms for biomedical research, pharmaceutical research, drug discovery, drug development, bioinformatics, computational biology, and drug safety research; Designing, hosting, maintaining, and updating searchable biomedical, scientific, pharmacological, drug development, and drug safety-related databases for scientific research and pharmaceutical research purposes; Designing, hosting, maintaining, and updating curated biomedical, pharmacological, drug development, and drug safety-related databases for scientific research, pharmaceutical research, computational drug discovery, and drug development research purposes; Providing platforms for integrating, curating, visualizing, and analyzing biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Providing platforms for integrating, curating, and analyzing biomedical knowledge graphs, molecular interaction networks, scientific literature-derived data, clinical trial data, pharmacological data, drug development data, and drug safety-related data; Scientific and technological consulting in the fields of genomics, bioinformatics, computational biology, biomedical data analytics, pharmacological data analytics, drug development data analytics, drug safety-related data analytics, API-based biomedical data analytics, and biomedical software integration; Scientific and technological services for computational drug discovery, including prediction of therapeutic indications, identification of drug targets, target validation, analysis of drug-target relationships, and identification of therapeutic opportunities; Scientific and technological services for computational drug discovery and drug development research, including analysis of drug-target relationships, molecular mechanisms, mechanisms of action, biomarkers, therapeutic opportunities, potential indications, clinical trial information, drug development status, and drug safety signals; Scientific and technological services for the integration, curation, and analysis of biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Data analytics services for identifying and evaluating molecular mechanisms, biomarkers, drug-target relationships, therapeutic opportunities, potential indications, drug development status, drug safety signals, toxicity risks, contraindications, and drug-drug interactions; Data analytics services for identifying molecular mechanisms, biomarkers, drug-target relationships, therapeutic opportunities, potential indications, and drug safety-related insights for scientific research, pharmaceutical research, computational drug discovery, and drug development research purposes |
| Indication of Colors claimed | The color(s) dark blue and blue is/are claimed as a feature of the mark. |
| Goods and Services | Providing non-clinical medical, genomic, biotechnological, and pharmaceutical information relating to biomedical research, pharmaceutical research, drug discovery, drug development, biomarkers, drug-target relationships, mechanisms of action, therapeutic indications, drug development status, and drug safety-related information; Providing non-clinical pharmaceutical and biomedical information derived from curated reference data, scientific publications, clinical trial data, biomedical knowledge graphs, pharmacological data, drug development data, and drug safety-related data for research-support purposes; Providing non-clinical information relating to adverse event information, toxicity information, contraindication information, drug-drug interaction information, risk information, pharmacovigilance-related information, and drug safety-related content for pharmaceutical research-support purposes; Providing non-clinical medical, genomic, biotechnological, and pharmaceutical information derived from computational analysis of drug-target relationships, molecular mechanisms, biomarkers, therapeutic opportunities, potential indications, drug development status, and drug safety signals; Advisory services relating to the non-clinical interpretation of biomedical, genomic, phenotypic, pharmacological, drug development, and drug safety-related data for pharmaceutical research, drug development, drug discovery, and research-support purposes; Providing non-clinical pharmaceutical research-support information derived from biomedical graph analytics, molecular interaction networks, curated biomedical databases, scientific publication-derived data, clinical trial information, pharmacological data, and drug safety-related data |
| Description of Mark | The mark consists of the term "LUCERA" in dark blue to the right of an open triangle outlined in dark blue, containing a shaded triangle in shades of blue. The color white is for background purposes only and is not part of the mark. |
| Goods and Services | Providing access to cloud-hosted biomedical, medical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related databases; Providing access to cloud-hosted databases containing curated biomedical reference data, scientific publication-derived information, clinical trial information, pharmacological information, drug development information, and drug safety-related information; Providing access to online software tools for biomedical, pharmacological, drug development, and drug safety-related data analysis; Providing access to online software tools and web-based algorithms for analyzing drug-target relationships, molecular mechanisms, biomarkers, therapeutic indications, drug development status, and drug safety-related information; Providing access to web-based algorithms and computational functions for interpreting biomedical data, biomedical knowledge graphs, molecular interaction networks, pharmacological data, clinical trial data, drug development data, and drug safety-related data; Providing access to web-based computational tools for interpreting adverse event information, toxicity information, contraindication information, drug-drug interaction information, risk information, pharmacovigilance-related information, and similar safety-related content; Providing access to application programming interfaces (APIs) for accessing, querying, integrating, and analyzing biomedical, genomic, phenotypic, pharmacological, clinical trial, drug development, and drug safety-related data; Providing access to web-based APIs and data interfaces for biomedical knowledge graphs, molecular interaction networks, curated biomedical reference data, scientific publication-derived data, pharmacological data, clinical trial data, drug development data, and drug safety-related data; Transmission and provision of access to digital scientific information, biomedical analytics platforms, pharmacological analytics platforms, drug development analytics platforms, drug safety-related analytics platforms, and API-based biomedical data analytics platforms |
